Navigation Links
News briefs from the July issue of CHEST
Date:7/6/2009

SMOKING CESSATION MAY PROVIDE IMMEDIATE BENEFIT TO HEART

A new article suggests smoking cessation provides immediate benefits to patients. Researchers from the Feinstein Institute for Medical Research in Manhasset, NY, examined specific inflammatory biomarkers associated with cardiovascular disease (CVD) in "at risk" women during the smoking cessation process. Results showed that smoking cessation resulted in significant reductions in circulating tumor necrosis factor (TNF), soluble TNF receptors I and II, and soluble vascular cell adhesion molecule-1 (VCAM-1). Researchers conclude that there are rapid consequences of smoking cessation on inflammatory biomarkers in women at risk for CVD. The article is published in the July issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians.

ELECTRICAL MUSCLE STIMULATION MAY BENEFIT PATIENTS WITH COPD

Patients with severe chronic obstructive pulmonary disease (COPD) or chronic heart failure (CHF) may be physically limited by the severity of their disease, potentially leading to skeletal muscular impairment or muscle atrophy. New research shows that these patients may benefit from neuromuscular electrical stimulation (NMES). Researchers from The Netherlands reviewed 14 trials that examined the use of NMES in patients with CHF and COPD. They found that many of the studies reported significant improvements in muscle strength, exercise capacity, and/or health status. Researchers conclude that, although NMES looks promising for patients with COPD and CHF, additional studies are warranted. This study is published in the July issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians.

DEATHS FROM PULMONARY FIBROSIS HIGHEST IN WINTER

New research shows that mortality from idiopathic pulmonary fibrosis (IPF) and/or pulmonary fibrosis (PF) may be highest during the winter months. Using death records from the National Center for Health Statistics, a research team from the University of Colorado Health Sciences Center in Denver, CO, calculated the monthly mortality rates for persons with PF. Results showed that mortality rates from PF significantly varied by season. The average mortality rate among all persons with PF was 17.1 percent higher in the winter, 12.7 percent higher in spring, and 5.2 percent higher in fall than in the summer months. This study is published in the July issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians.

LONG-ACTING β2-AGONISTS MAY NOT BENEFIT ASTHMA PATIENTS

New research shows that long-acting β2-agonists (LABAs) may not have a clinically significant antiinflammatory effect as once believed. LABAs are recommended as add-on therapy to antiinflammatory treatment in chronic persistent asthma. However, in a metaanalysis of 32 studies (n=1,105 patients), researchers from McMaster University in Ontario, Canada, found that LABA therapy had no effect on sputum, bronchoalveolar lavage (BAL), or mucosal inflammatory cell findings in adults or children. LABAs did decrease exhaled nitric oxide levels and BAL albumin levels in adults, suggesting a possible benefit. The study is published in the July issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians.


'/>"/>

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Related medicine news :

1. News briefs from the June issue of CHEST
2. Journal Chest: April news briefs
3. Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs)
4. Journal Chest: March news briefs
5. Preparing for the Next Disaster: Dialysis Community Briefs Hill About Emergency Response
6. Journal Chest: January news briefs
7. News briefs from the American Society of Plastic Surgery
8. Chest Journal: August news briefs
9. News briefs from the American Society of Plastic Surgeons
10. News briefs from the American Society of Plastic Surgeons
11. Weill Cornell science briefs May 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... ... to fertility once they have been diagnosed with endometriosis. These women need a ... they also require a comprehensive approach that can help for preservation of fertility ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology: